PRKN and neoplasm: GPR37 was previously identified as the receptor of Parkin, an E3 ubiquitin ligase encoded by PARK2, involved in ubiquitination and proteasome mediated degradation/clearance of misfolding proteins, which is closely related to tumor development [45–47].